- Home
- ALRN vs SGA Comparison
ALRN vs SGA Comparison
Compare ALRN & SGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALRN
- SGA
- Stock Information
- Founded
- ALRN 2001
- SGA 1986
- Country
- ALRN United States
- SGA United States
- Employees
- ALRN N/A
- SGA N/A
- Industry
- ALRN Biotechnology: Pharmaceutical Preparations
- SGA Broadcasting
- Sector
- ALRN Health Care
- SGA Consumer Discretionary
- Exchange
- ALRN Nasdaq
- SGA Nasdaq
- Market Cap
- ALRN 76.9M
- SGA 89.2M
- IPO Year
- ALRN 2017
- SGA 1992
- Fundamental
- Price
- ALRN $1.92
- SGA $12.12
- Analyst Decision
- ALRN Strong Buy
- SGA
- Analyst Count
- ALRN 1
- SGA 0
- Target Price
- ALRN $19.00
- SGA N/A
- AVG Volume (30 Days)
- ALRN 92.8K
- SGA 18.6K
- Earning Date
- ALRN 11-14-2024
- SGA 11-07-2024
- Dividend Yield
- ALRN N/A
- SGA 8.37%
- EPS Growth
- ALRN N/A
- SGA N/A
- EPS
- ALRN N/A
- SGA 0.75
- Revenue
- ALRN N/A
- SGA $110,669,000.00
- Revenue This Year
- ALRN N/A
- SGA N/A
- Revenue Next Year
- ALRN N/A
- SGA $2.95
- P/E Ratio
- ALRN N/A
- SGA $15.92
- Revenue Growth
- ALRN N/A
- SGA N/A
- 52 Week Low
- ALRN $1.61
- SGA $11.65
- 52 Week High
- ALRN $7.42
- SGA $24.80
- Technical
- Relative Strength Index (RSI)
- ALRN 29.69
- SGA 42.94
- Support Level
- ALRN $1.85
- SGA $11.65
- Resistance Level
- ALRN $2.38
- SGA $13.12
- Average True Range (ATR)
- ALRN 0.30
- SGA 0.40
- MACD
- ALRN -0.01
- SGA 0.06
- Stochastic Oscillator
- ALRN 6.31
- SGA 31.54
About ALRN Aileron Therapeutics Inc.
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.
About SGA Saga Communications Inc. (FL)
Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets and It derives a majority of its revenue from the sale of advertising for broadcast on its stations.